Related Experiment Video

Updated: Aug 16, 2026

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine
10:05

Testing the Efficacy of Pharmacological Agents in a Pericardial Target Delivery Model in the Swine

Published on: July 7, 2016

Pharmacotherapy in congestive heart failure: Hyperkalemia in congestive heart failure

T WB Gehr1, D A Sica

  • 1Department of Medicine, Division of Nephrology, Medical College of Virginia, Virginia Commonwealth University, Richmond, VA 23298.

Congestive Heart Failure (Greenwich, Conn.)
|February 6, 2002
PubMed

Insights

Hyperkalemia, or high potassium, is a common medication side effect in congestive heart failure patients, especially with kidney issues. Management involves acute treatment and prevention through careful medication management.

Area of Science:

  • Cardiology
  • Nephrology
  • Clinical Pharmacology

Background:

  • Hyperkalemia frequently affects congestive heart failure (CHF) patients, often exacerbated by coexisting renal failure.
  • Medication-induced hyperkalemia is prevalent in CHF, linked to drugs like ACE inhibitors, beta-blockers, and aldosterone antagonists.

Purpose of the Study:

  • To review the occurrence, consequences, and management of hyperkalemia in congestive heart failure patients.
  • To highlight the cardiotoxic risks and therapeutic strategies for hyperkalemia in this population.

Main Methods:

  • Review of existing literature on hyperkalemia in CHF.
  • Discussion of acute and semiacute management strategies.
  • Emphasis on preventative measures and medication titration.

Main Results:

  • Hyperkalemia in CHF is often medication-related, particularly with ACE inhibitors, beta-blockers, and aldosterone antagonists.
  • Cardiotoxicity is a significant, potentially insidious consequence of hyperkalemia.
  • Acute management includes calcium, bicarbonate, and beta-agonists; semiacute management involves potassium excretion enhancers and binding resins.

Conclusions:

  • Prevention is key, requiring identification of potassium sources and optimal dosing of renin-angiotensin system inhibitors.
  • Comprehensive management involves both acute interventions and long-term preventative strategies.
  • Careful monitoring and medication adjustment are crucial for managing hyperkalemia in CHF patients.

More Related Videos

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing12:45

Benefits of Cardiac Resynchronization Therapy in an Asynchronous Heart Failure Model Induced by Left Bundle Branch Ablation and Rapid Pacing

Published on: December 11, 2017

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique08:11

Voltage-Dependent Potassium Current Recording on H9c2 Cardiomyocytes via the Whole-Cell Patch-Clamp Technique

Published on: November 11, 2022

Related Concept Videos

Heart Failure Drugs: Inotropic Agents01:26

Heart Failure Drugs: Inotropic Agents

Positive inotropic agents are commonly used as the first line of treatment for heart failure. One such agent is digoxin, derived from the genus Digitalis, which has been known for centuries but effectively utilized since 1785. However, these cardiac glycosides can have potentially toxic effects due to their mechanism of action, which involves inhibiting Na+/K+-ATPase and increasing contractility. Digoxin is absorbed orally and distributed in various tissues, including the CNS. It has a long...
Heart Failure Drugs: Diuretics01:22

Heart Failure Drugs: Diuretics

Heart failure and kidney perfusion are interconnected in a complex way. Reduced renal perfusion and venous congestion are two significant factors that contribute to renal dysfunction in heart failure. The kidneys, primarily responsible for fluid balance in the body, are adversely affected due to compromised cardiac output and increased venous pressure. In response to reduced renal perfusion, the kidneys activate neurohumoral mechanisms to restore balance. However, these mechanisms can be...
Heart Failure Drugs: Inhibitors of Renin-Angiotensin System01:26

Heart Failure Drugs: Inhibitors of Renin-Angiotensin System

The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...